Open Label, Single Center Study to Evaluate Higher Doses of Daptomycin in the Treatment of Patients With Severe Necrotizing Skin and Soft Tissue Infections.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 13 Dec 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Daptomycin (Primary)
Indications Fasciitis; Fournier gangrene; Gram-positive infections; Skin and soft tissue infections
Focus Therapeutic Use

30 May 2008 The expected completion date for this trial is now 1 May 2008, according to ClinicalTrials.gov.
30 May 2008 Status changed from recruiting to completed, reported by ClinicalTrials.gov.
09 Jul 2007 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com